المؤلفون: Bart Neyns, Christian U. Blank, Michal Lotem, Mark R. Middleton, J.-J. Grob, Melanie A. Leiby, Antoni Ribas, C. Robert, Jacob Schachter, Céleste Lebbé, Euan Walpole, Matteo S. Carlino, Neil Steven, Nageatte Ibrahim, Peter Mohr, A. Arance, Paul Lorigan, Mario Sznol, Erin Jensen, Georgina V. Long, Laurent Mortier

المساهمون: Faculty of Law and Criminology, Medical Oncology, Clinical sciences, Laboratory of Molecular and Medical Oncology, Faculty of Arts and Philosophy

المصدر: Long, G V, Arance, A, Mortier, L, Lorigan, P, Blank, C, Mohr, P, Schachter, J, Grob, J-J, Lotem, M, Middleton, M R, Neyns, B, Steven, N, Ribas, A, Walpole, E, Carlino, M S, Lebbe, C, Sznol, M, Jensen, E, Leiby, M A, Ibrahim, N & Robert, C 2022, ' Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma : analysis from KEYNOTE-006 ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 33, no. 2, pp. 204-215 . https://doi.org/10.1016/j.annonc.2021.10.010Test

مصطلحات موضوعية: Proto-Oncogene Proteins B-raf, advanced melanoma, Oncology, BRAF inhibition, medicine.medical_specialty, Ipilimumab, Pembrolizumab, Antibodies, Monoclonal, Humanized, Internal medicine, medicine, Humans, In patient, ipilimumab, Melanoma, Complete response, Advanced melanoma, Mitogen-Activated Protein Kinase Kinases, Antitumor activity, Manchester Cancer Research Centre, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Hematology, medicine.disease, MEK inhibition, pembrolizumab, business, Progressive disease, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ae40264769d12ae7ca2fde50f109b8fTest
https://doi.org/10.1016/j.annonc.2021.10.010Test

المؤلفون: Michael Millward, V. Atkinson, Sandip Pravin Patel, Christoph Hoeller, Christian U. Blank, Andrew Haydon, Alexander N. Shoushtari, Reinhard Dummer, Alexander M. Menzies, James Larkin, Carina N. Owen, Arissa Young, Maartje W. Rohaan, Dharmisha Chauhan, Shahneen Sandhu, Douglas B. Johnson, J. Mangana, Georgina V. Long, D. Palmieri, Matteo S. Carlino, Serigne Lo, Muhammad A. Khattak, Farzana Y Zaman, Peter Hersey, Belinda Lee

المصدر: Ann Oncol

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Ipilimumab, Gastroenterology, Article, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Adjuvant therapy, Humans, Stage (cooking), Melanoma, Hematology, business.industry, Mucosal melanoma, medicine.disease, Combined Modality Therapy, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Cutaneous melanoma, Immunotherapy, business, Adjuvant, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b83e339b674f679f965aaea6b9ddf88Test
https://doi.org/10.1016/j.annonc.2020.04.471Test

المؤلفون: B.A. van de Wiel, Charlotte L. Zuur, Serigne Lo, Michel W.J.M. Wouters, Carolien Bierman, María Jesús González González, Elena Shklovskaya, Christian U. Blank, Willem M.C. Klop, Elisa A. Rozeman, Robert V. Rawson, J.B.A.G. Haanen, Omgo E. Nieweg, James S. Wilmott, Andrew J. Spillane, Robyn P. M. Saw, J.V. van Thienen, C. Adhikari, Sydney Ch'ng, A.C.J. van Akkooi, Michael T. Tetzlaff, Hanna Eriksson, Helen Rizos, Alexander Guminski, Richard A. Scolyer, Kerwin F. Shannon, W.J. van Houdt, Jonathan R. Stretch, Georgina V. Long, A.M. Menzies

المصدر: Annals of Oncology, 32(6), 766-777. ELSEVIER

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Ipilimumab, 03 medical and health sciences, 0302 clinical medicine, Fibrosis, Internal medicine, medicine, Humans, Melanoma, Pathological, Lymph node, business.industry, neoadjuvant, Reproducibility of Results, Hematology, Immunotherapy, medicine.disease, Neoadjuvant Therapy, 030104 developmental biology, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Biomarker (medicine), immunotherapy, Nivolumab, business, pathological response, medicine.drug, metastatic melanoma

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffb61a837c13200f2514a9ed7c1f22afTest
https://hdl.handle.net/1887/3276136Test

المؤلفون: Ieva Kurilova, Regina G. H. Beets-Tan, Ferry Lalezari, S.G. Drago, A. Delli Pizzi, J.B.A.G. Haanen, Chintan Parmar, Maartje W. Rohaan, Stefano Trebeschi, Doenja M. J. Lambregts, Elisa A. Rozeman, Egbert F. Smit, Nicolai Juul Birkbak, Koen J. Hartemink, A.M. Cǎlin, Charles Swanton, Christian U. Blank, Hugo J.W.L. Aerts

المساهمون: Promovendi ODB, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Faculteit FHML Centraal

المصدر: Trebeschi, S, Drago, S G, Birkbak, N J, Kurilova, I, Cǎlin, A M, Delli Pizzi, A, Lalezari, F, Lambregts, D M J, Rohaan, M W, Parmar, C, Rozeman, E A, Hartemink, K J, Swanton, C, Haanen, J B A G, Blank, C U, Smit, E F, Beets-Tan, R G H & Aerts, H J W L 2019, ' Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers ', Annals of Oncology, vol. 30, no. 6, mdz108, pp. 998-1004 . https://doi.org/10.1093/annonc/mdz108Test
Technology in Cancer Research & Treatment
Annals of Oncology, 30(6), 998-1004. Oxford University Press
Annals of Oncology

مصطلحات موضوعية: 0301 basic medicine, Oncology, SELECTION, Lung Neoplasms, BLOCKADE, medicine.medical_treatment, FEATURES, Programmed Cell Death 1 Receptor, 0302 clinical medicine, Cancer immunotherapy, Neoplasms, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, PD-1, Melanoma, Letter to the Editor, DOCETAXEL, RISK, Special Collection on Current Technologies in Targeted Cancer Immunotherapies, Hematology, Prognosis, artificial intelligence, 3. Good health, Survival Rate, machine learning, radiomics, 030220 oncology & carcinogenesis, Biomarker (medicine), immunotherapy, SENSITIVITY, Algorithms, EXPRESSION, medicine.medical_specialty, CELL LUNG-CANCER, medical imaging, 03 medical and health sciences, Onco-Immunology, Predictive Value of Tests, Internal medicine, medicine, Medical imaging, Immunologic Factors, Humans, Lung cancer, SIGNATURES, Noninvasive biomarkers, business.industry, Cancer, NIVOLUMAB, Immunotherapy, medicine.disease, Original articles, Editor's Choice, 030104 developmental biology, response prediction, business, Tomography, X-Ray Computed, Biomarkers, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fd03537dc5d67fb40abb417868a1cc9Test
https://doi.org/10.1093/annonc/mdz108Test

المؤلفون: A. Daletzakis, M.S. van der Heijden, N. van Dijk, Christian U. Blank, Kees Hendricksen, Niven Mehra, Thierry N. Boellaard, B.B.M. Suelmann, Richard P. Meijer, M.L. Van Montfoort, J. van Dorp, J.M. De Feijter, T. van der Heijden, B.W.G. Van Rhijn

المصدر: Annals of Oncology. 32:S1305-S1306

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Low dose, Ipilimumab, Hematology, Pre operative, Internal medicine, Cohort, medicine, Urothelial cancer, Nivolumab, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4ebd3a07119036e271010472aa66aff1Test
https://doi.org/10.1016/j.annonc.2021.08.2107Test

المؤلفون: Ellen Kapiteijn, Christian U. Blank, A.J.M. van den Eertwegh, J.B.A.G. Haanen, Marye J Boers-Sonderen, Djura Piersma, Michel W.J.M. Wouters, M.M. De Meza, Karijn P M Suijkerbuijk, F.W.P.J. van den Berkmortel, Willeke A. M. Blokx, Rawa K Ismail, A.A.M. Van der Veldt, Mieke J. Aarts, J.W.B. de Groot, G. Vreugdenhil, A.C.J. van Akkooi, H.M. Westgeest, R van Rijn, Gap Hospers

المصدر: Annals of Oncology. 32:S888-S889

مصطلحات موضوعية: Oncology, Clinical Practice, medicine.medical_specialty, business.industry, Melanoma, medicine.medical_treatment, Internal medicine, medicine, Hematology, medicine.disease, business, Adjuvant

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::5d8c4e19d2aab0f6d5aa108ac80441f4Test
https://doi.org/10.1016/j.annonc.2021.08.1455Test

المؤلفون: Christian U. Blank, Willem M.C. Klop, N. Kapsali, N.M.J. Van Den Heuvel, Richard A. Scolyer, Michel W.J.M. Wouters, Georgina V. Long, Irene L.M. Reijers, M.J.C. Gregorio, Andrew J. Spillane, B.A. van de Wiel, L.V. van de Poll-Franse, Andrew J. Colebatch, A.M. Menzies, Jacobien M. Kieffer, Robyn P. M. Saw, A.C.J. van Akkooi, Annelies H. Boekhout, Thomas E. Pennington, Judith M. Versluis

المصدر: Annals of Oncology. 32:S1100-S1101

مصطلحات موضوعية: Health related quality of life, Oncology, medicine.medical_specialty, business.industry, Internal medicine, Melanoma, medicine, Hematology, Nivolumab, medicine.disease, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::bc59dbd730f7d2f1fc8439fe8fd01746Test
https://doi.org/10.1016/j.annonc.2021.08.828Test

المؤلفون: N. Thompson, Christian U. Blank, Adnan Khattak, Alice Labianca, A. Arance, T. Quah, Wen Xu, Clara Allayous, C. Martínez-Vila, Ryan J. Sullivan, Roslyn Wallace, P.A. Ascierto, Sarah J. Welsh, Carina N. Owen, Shahneen Sandhu, Prachi Bhave, V. Vanella, Xue Bai, Jennifer L. McQuade, Céleste Lebbé, Bart Neyns, Matteo S. Carlino, Irene L.M. Reijers, J. Mangana, Serigne Lo, Sophia Callaghan, Mario Mandalà, Sandrine Aspeslagh, Olivier Michielin, Camille L. Gerard, Paul Lorigan, Douglas B. Johnson, Andrew Haydon, Lisa Zimmer, Georgina V. Long, A.M. Menzies

المساهمون: Faculty of Sciences and Bioengineering Sciences, Laboratory for Medical and Molecular Oncology, Clinical sciences, Medical Oncology, Faculty of Psychology and Educational Sciences, Physics

المصدر: Owen, C N, Bai, X, Quah, T, Lo, S N, Allayous, C, Callaghan, S, Martínez-Vila, C, Wallace, R, Bhave, P, Reijers, I L M, Thompson, N, Vanella, V, Gerard, C L, Aspeslagh, S, Labianca, A, Khattak, A, Mandala, M, Xu, W, Neyns, B, Michielin, O, Blank, C U, Welsh, S J, Haydon, A, Sandhu, S, Mangana, J, McQuade, J L, Ascierto, P A, Zimmer, L, Johnson, D B, Arance, A, Lorigan, P, Lebbé, C, Carlino, M S, Sullivan, R J, Long, G V & Menzies, A M 2021, ' Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma ', Annals of Oncology, vol. 32, no. 7, pp. 917-925 . https://doi.org/10.1016/j.annonc.2021.03.204Test

مصطلحات موضوعية: 0301 basic medicine, Pediatrics, medicine.medical_specialty, delayed, medicine.medical_treatment, Medizin, 03 medical and health sciences, 0302 clinical medicine, irAE, medicine, melanoma, Humans, Immunologic Factors, anti-PD1, Adverse effect, Pneumonitis, Retrospective Studies, Manchester Cancer Research Centre, business.industry, Melanoma, Incidence (epidemiology), ResearchInstitutes_Networks_Beacons/mcrc, toxicity, Hematology, Immunotherapy, Pneumonia, medicine.disease, Rash, Anti-PD-1, Confidence interval, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, anti-PD-1, immunotherapy, medicine.symptom, business, Encephalitis

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13b5c19117384b568cfd2a11dbc3489cTest
http://hdl.handle.net/11391/1491436Test

المؤلفون: Katarzyna Jozwiak, Annelies H. Boekhout, Christian U. Blank, G. Vreugdenhil, Ellen Kapiteijn, Karijn P M Suijkerbuijk, D Piersma, Geke A. P. Hospers, A.A.M. Van der Veldt, Marye J Boers-Sonderen, K.J. Janssen, L.V. van de Poll-Franse, A.J. ten Tije, J.W.B. de Groot, Maureen J.B. Aarts, Bart Neyns, Elisa A. Rozeman, Anne Rogiers, A.J.M. van den Eertwegh

المساهمون: Medical Oncology, Faculty of Medicine and Pharmacy, Radiation Therapy, Clinical sciences, Laboratory for Medical and Molecular Oncology, Laboratory of Molecullar and Cellular Therapy, Mathematics-TW, CCA - Cancer Treatment and quality of life, AII - Cancer immunology, Medical oncology, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: Acta Oncologica, 60(1), 69-77. Informa Healthcare
Acta Oncologica, 60, 1, pp. 69-77
Acta Oncologica, 60, 69-77
Acta Oncologica, 60(1), 69-77. Routledge/Taylor & Francis Group
ACTA ONCOLOGICA, 60(1), 69-77. Taylor & Francis Ltd
Acta Oncologica, 60(1), 69-77. TAYLOR & FRANCIS LTD
Boekhout, A H, Rogiers, A, Jozwiak, K, Boers-Sonderen, M J, van den Eertwegh, A J, Hospers, G A, de Groot, J W B, Aarts, M J B, Kapiteijn, E, ten Tije, A J, Piersma, D, Vreugdenhil, G, van der Veldt, A A, Suijkerbuijk, K P M, Rozeman, E A, Neyns, B, Janssen, K J, van de Poll-Franse, L V & Blank, C U 2021, ' Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls ', Acta Oncologica, vol. 60, no. 1, pp. 69-77 . https://doi.org/10.1080/0284186X.2020.1818823Test

مصطلحات موضوعية: Oncology, IMPACT, EUROPEAN-ORGANIZATION, Pembrolizumab, FATIGUE, 030218 nuclear medicine & medical imaging, 0302 clinical medicine, Quality of life, Cancer Survivors, Surveys and Questionnaires, Survivors, Immune Checkpoint Inhibitors, Melanoma, OUTCOMES, Hematology, INSTRUMENT, General Medicine, DEPRESSION, CANCER, RESECTED STAGE-III, health-related quality of life, 030220 oncology & carcinogenesis, immune checkpoint inhibition, Nivolumab, medicine.drug, medicine.medical_specialty, Ipilimumab, HOSPITAL ANXIETY, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], 03 medical and health sciences, SDG 3 - Good Health and Well-being, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, PEMBROLIZUMAB, neoplasms, matched controls, business.industry, IPILIMUMAB, Cancer, NIVOLUMAB, medicine.disease, Immune checkpoint, Quality of Life, sense organs, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edd09e256f654f4b814df9e2ceaa80f7Test
https://hdl.handle.net/20.500.14017/61e967f1-5267-4479-89e5-66dfa5bcacc3Test

المؤلفون: A.J.M. van den Eertwegh, E.W. van Zwet, Jesper van Breeschoten, L. de Wreede, G. Vreugdenhil, Christian U. Blank, Karijn P M Suijkerbuijk, J.B.A.G. Haanen, Mieke J. Aarts, R van Rijn, J.W.B. de Groot, A.A.M. Van der Veldt, F.W.P.J. van den Berkmortel, Djura Piersma, Marion Stevense, Ellen Kapiteijn, Doranne L. Hilarius, Marye J Boers-Sonderen, Gap Hospers, Michel W.J.M. Wouters

المصدر: Annals of Oncology. 32:S896

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Variation (linguistics), business.industry, Internal medicine, Medicine, Cancer, Hematology, business, medicine.disease, Quality assurance, Advanced melanoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::227cff5f5bdb36bcf519a2199f275648Test
https://doi.org/10.1016/j.annonc.2021.08.1466Test